Ravi Srinivas Chaturvedula
Strategic Business Planning and Implementation | Pharmaceutical Sales & Distribution | Pharmaceutical Products Knowledge | New Business Development | Institutional Sales | Key/Strategic Accounts Acquisition and Management | Product Launches | Brand Positioning and Awareness | Market Share Improvement I Database Management | Expenses Planning & Control | Coaching & Mentoring I Customer/Stakeholder Relations Improvement Organizational Restructuring & Administrative Skills I Team Leadership and Motivation | Communication and Inter-Personal skills
Work & Experience
Accelerated productivity consistently over the last 4 years, with sales growth of 0.88% in 2022 compared to 2021, 16.5% in 2021 compared to 2020, and over 20% growth in 2020 compared to 2019. Played a key role in maintaining good business practices by reducing operational costs such as inventory, expired products, Goods Received Notes (GRN) and outstanding payments at distributor the level. Led significant initiatives to reduce waste, resulting in 0.10% of sales in 2022, 0.11% of sales in 2021, 0.15% of sales in 2020, and 0.14% of sales in 2019. Trusted in identifying business obstacles and developing custom products for individual markets by conducting meetings and collaborating with the senior leadership team and cross-functional teams in the organization. Achieved business objectives and increased brand visibility by establishing strong relationships with key opinion leaders (KOLs) and internal stakeholders. Controlled and monitored team performance towards compliance and ethical working by engaging the team and tracking their performances.
Framed the initial sales roadmap and implemented strategies across Andhra Pradesh and Karnataka for the Epilepsy portfolio, along with robust customer relationship management (CRM) activities for the Neuro-taskforce division was launched in 2011; over 100 camps were conducted, and around 5000 Epilepsy patients were screened, resulting in a 24% growth in the Epilepsy franchise Revamped the sales team and implemented the strategy to consolidate both internal customers and prescribers in a new market in Karnataka. As a result, there was zero attrition in the area and an 80% increase in the prescriber base. Achieved sales of 101% with 7.3% growth in 2015 and a Wastage reduction is 0.1% in sales. Improved Epilepsy portfolio in 3 states with a growth of over 24% in the above period with help of Patient screening camps & Therapy awareness initiatives
Guided and built a high-performing sales team across Coastal AP. Mentored the assigned team to position its performance at 96% with a growth of 9% in the 1st year.
Launched brands like Zolfresh & Epilex Chrono in the field of Insomnia & Epilepsy that have beaten market growth. Zolfresh grew by 27%, while Epilex Chrono grew by 19% more than the market in 2009